These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38429734)

  • 1. Changes of Mycobacterium tuberculosis specific antigen-stimulated CD27
    Fang Y; Tang Y; Luo QX; Wang N; Tang L; Yang XJ; You XF; Wang YC; Liang L; Zhang JB; Su B; Sha W
    Eur J Med Res; 2024 Mar; 29(1):147. PubMed ID: 38429734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of CD27, CD38, HLA-DR and Ki-67 immune profiles for the characterization of active tuberculosis, latent infection and end of treatment.
    Díaz-Fernández S; Villar-Hernández R; Stojanovic Z; Fernández M; Galvão MLS; Tolosa G; Sánchez-Montalva A; Abad J; Jiménez-Fuentes MÁ; Safont G; Romero I; Sabrià J; Prat C; Domínguez J; Latorre I
    Front Microbiol; 2022; 13():885312. PubMed ID: 35935194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Mycobacterium tuberculosis specific antigen-stimulated CD27
    Fang Y; Wang N; Tang L; Yang XJ; Tang Y; Li L; Wu WF; Su B; Sha W
    BMC Infect Dis; 2022 Dec; 22(1):899. PubMed ID: 36457066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of CD27 and CCR4 Markers on Specific CD4
    Latorre I; Fernández-Sanmartín MA; Muriel-Moreno B; Villar-Hernández R; Vila S; Souza-Galvão ML; Stojanovic Z; Jiménez-Fuentes MÁ; Centeno C; Ruiz-Manzano J; Millet JP; Molina-Pinargote I; González-Díaz YD; Lacoma A; Luque-Chacón L; Sabriá J; Prat C; Domínguez J
    Front Immunol; 2018; 9():3094. PubMed ID: 30687314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of CD27 expression on T-cells as a diagnostic and therapeutic tool for patients with smear-negative pulmonary tuberculosis.
    Xu F; Zhang H; Si X; Chen J; Chen Y; Cui X; Qin Y
    BMC Immunol; 2021 Jun; 22(1):41. PubMed ID: 34176483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of CD27 expression as a tool for active and latent tuberculosis diagnosis.
    Petruccioli E; Petrone L; Vanini V; Cuzzi G; Navarra A; Gualano G; Palmieri F; Girardi E; Goletti D
    J Infect; 2015 Nov; 71(5):526-33. PubMed ID: 26253021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis.
    Adekambi T; Ibegbu CC; Kalokhe AS; Yu T; Ray SM; Rengarajan J
    PLoS One; 2012; 7(4):e36046. PubMed ID: 22545156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of phenotype and absolute number of circulating heparin-binding hemagglutinin, ESAT-6 and CFP-10, and purified protein derivative antigen-specific CD4 T cells can discriminate active from latent tuberculosis infection.
    Hutchinson P; Barkham TM; Tang W; Kemeny DM; Chee CB; Wang YT
    Clin Vaccine Immunol; 2015 Feb; 22(2):200-12. PubMed ID: 25520147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mtb-specific CD27low CD4 T cells as markers of lung tissue destruction during pulmonary tuberculosis in humans.
    Nikitina IY; Kondratuk NA; Kosmiadi GA; Amansahedov RB; Vasilyeva IA; Ganusov VV; Lyadova IV
    PLoS One; 2012; 7(8):e43733. PubMed ID: 22937086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.
    Adekambi T; Ibegbu CC; Cagle S; Kalokhe AS; Wang YF; Hu Y; Day CL; Ray SM; Rengarajan J
    J Clin Invest; 2015 May; 125(5):1827-38. PubMed ID: 25822019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring Anti-tuberculosis Treatment Response Using Analysis of Whole Blood
    Vickers MA; Darboe F; Muefong CN; Mbayo G; Barry A; Gindeh A; Njie S; Riley AJ; Sarr B; Sambou B; Dockrell HM; Charalambous S; Rachow A; Owolabi O; Jayasooriya S; Sutherland JS
    Front Immunol; 2020; 11():572620. PubMed ID: 33679684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy.
    Mattos AM; Almeida Cde S; Franken KL; Alves CC; Abramo C; de Souza MA; L'Hotellier M; Alves MJ; Ferreira AP; Oliveira SC; Ottenhoff TH; Teixeira HC
    Int Immunol; 2010 Sep; 22(9):775-82. PubMed ID: 20624776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of CD4 and CD8 T cells producing IFN-γ in human latent and active tuberculosis.
    Rueda CM; Marín ND; García LF; Rojas M
    Tuberculosis (Edinb); 2010 Nov; 90(6):346-53. PubMed ID: 20933471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helminth species-specific effects on IFN-γ producing T cells during active and latent tuberculosis.
    Kiflie A; Bewket G; Tajebe F; Abate E; Schӧn T; Blomgran R
    PLoS Negl Trop Dis; 2023 Jan; 17(1):e0011094. PubMed ID: 36662839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rv2204c, Rv0753c and Rv0009 antigens specific T cell responses in latent and active TB - a flow cytometry-based analysis.
    Pathakumari B; Devasundaram S; Maddineni P; Raja A
    Int J Med Microbiol; 2018 Mar; 308(2):297-305. PubMed ID: 29325881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy.
    Ahmed MIM; Ntinginya NE; Kibiki G; Mtafya BA; Semvua H; Mpagama S; Mtabho C; Saathoff E; Held K; Loose R; Kroidl I; Chachage M; von Both U; Haule A; Mekota AM; Boeree MJ; Gillespie SH; Hoelscher M; Heinrich N; Geldmacher C
    Front Immunol; 2018; 9():2247. PubMed ID: 30323818
    [No Abstract]   [Full Text] [Related]  

  • 18. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection.
    Yang X; Wu JB; Liu Y; Xiong Y; Ji P; Wang SJ; Chen Y; Zhao GP; Lu SH; Wang Y
    Tuberculosis (Edinb); 2017 Dec; 107():119-125. PubMed ID: 29050758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-functional flow cytometry analysis of CD4+ T cells as an immune biomarker for latent tuberculosis status in patients treated with tumour necrosis factor (TNF) antagonists.
    Sauzullo I; Scrivo R; Mengoni F; Ermocida A; Coppola M; Valesini G; Vullo V; Mastroianni CM
    Clin Exp Immunol; 2014 Jun; 176(3):410-7. PubMed ID: 24528189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.